[3P-033] Development of an aptamer-based PROTAC for inhibition of oncogenic ADAR1 for novel cancer therapy

^○Madhu Biyani², Yasuhiro Isogai³, Yui Sugai¹, Hinako Akashi¹, Shoei Maeda¹, Masataka Nakano^1,2, Miki Nakajima^1,2 (1.Drug Meta. and Toxico., Faculty of Pharma. Sci., Kanazawa Univ., 2.WPI-NanoLSI, Kanazawa Univ., 3.Dept. of Pharm. Engi., Toyama Pref. Univ.)